Breast Cancer: Genomic Testing for Adjuvant Therapy

Omitting Adjuvant Chemotherapy in Older Patients with High-Risk, HR+ Breast Cancer: The ASTER TrialПодробнее

Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at Hig...Подробнее

What's New in Screening and Treatment for Lobular Breast CancerПодробнее

What is Genomic Testing for Breast Cancer? Virginia Cancer SpecialistsПодробнее

Cancer Education Series: Breast Cancer UpdateПодробнее

Catalina Lopez Correa - Biomarkers ConferenceПодробнее

Education Session: Trends in Adjuvant Endocrine TherapyПодробнее

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline UpdateПодробнее

Understanding Your Breast Cancer Diagnosis And Treatment PlanПодробнее

Empowering the Patient Voice: Genomic Testing and Cancer Care DecisionsПодробнее

Diagnostics in Early BC—Who, Which Test, When | Maysa Abu-Khalaf, MD | ESMO22 PennsylvaniaПодробнее

Updates in Systemic Therapy for Breast Cancer 2/8/23Подробнее

Practical guide on molecular testing in breast cancer byProf Abeer ShabanПодробнее

Dr. Melinda Telli | Sa Antonio Breast Cancer Symposium 2022 | Clinical Research WorkshopПодробнее

BRCA-Positive Early-stage Breast Cancer: Treatment and TestingПодробнее

Early breast cancer: do we need chemotherapy in low genomic/high clinical risk (ER+/HER2-)?Подробнее

IASO Masterclass- Hereditary Breast CancerПодробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

Dr. Charles Perou | Distinguished Lectureship in Breast Cancer Research | SABCS 2022Подробнее

How Do Genomic Testing Results Impact Breast Cancer Treatment Options?Подробнее